Signaling pathways
-
BA5718 CAY10580Summary: CAY10580 is a potent and selective prostaglandin EP4 receptor agonist. - BA5719 GSK726701ASummary: GSK726701A is a partial agonist.
- BA5720 AAT-008Summary: A potent, selective, orally active prostaglandin receptor antagonist.
- BA5721 HHS-0701Summary: HHS-0701, a sulfur-triazole exchange (SuTEx) ligand, is a potent tyrosine-responsive prostaglandin reductase 2 inhibitor.
- BA5722 CarboprostSummary: Carboprost (15(S)-15-MethylProstaglandinF2α) is a metabolically stable synthetic analog of prostaglandin F2α.
- BA5723 PexopiprantSummary: Pexopiprant is an oral antagonist of prostaglandin D2 receptor 2 (DP2), <100nM.
- BA5724 GSK-269984ASummary: GSK-269984A is an antagonist of prostaglandin E2 receptor 1.
- BA5725 BI-671800Summary: BI-671800 is a highly specific and potent antagonist of the prostaglandin D2 receptor.
- BA5726 AganepagSummary: Aganepag (AGN210937) is a prostaglandin-like receptor agonist.
- BA5727 PicotamideSummary: Picotamide is a combined synthase and receptor inhibitor.